AI assistant
Sending…
VERU INC. — Director's Dealing 2009
Dec 1, 2009
34598_dirs_2009-12-01_63c6bb5f-2c49-4d6c-a9b7-58d0a59b84a9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: FEMALE HEALTH CO (FHCO)
CIK: 0000863894
Period of Report: 2009-09-11
Reporting Person: POPE MICHAEL (VP and General Manager)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-09-11 | Common Stock, par value $.01 per share | M | 72800 | $1.4 | Acquired | 73050 | Direct |
| 2009-09-14 | Common Stock, par value $.01 per share | S | 15000 | $5.8179 | Disposed | 58050 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-09-11 | Common Stock Option | $1.4 | M | 72800 | Disposed | 2013-04-22 | Common Stock (72800) | Direct |
Footnotes
F1: Upon request by the Commission staff, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
F2: The price reported above is the average transaction price. The range of prices for such transactions is $5.750 to $5.880.
F3: All options are fully vested. Options for one thirty-sixth of the shares vested on the 22nd of each month for the 36-month period commencing April 22, 2003 and ending on April 22, 2006.
More from VERU INC.
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 16
Regulatory Filings
2026
Apr 16
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 13
Major Shareholding Notification
2026
Feb 17
Regulatory Filings
2026
Feb 11